Tech Company Financing Transactions
Octave Bioscience Funding Round
Octave Bioscience secured a funding round on 10/13/2021. Backers included Merck Global Health Innovation Fund.
Transaction Overview
Company Name
Announced On
10/13/2021
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
Merck Global Health Innovation Fund (David Rubin)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
1440 O'Brien Dr. B
Menlo Park, CA 94025
USA
Menlo Park, CA 94025
USA
Phone
Website
Email Address
Overview
Octave is developing a comprehensive, first-in-class Care Management Platform. Our team has developed novel measurement tools that feed into structured analytical data models, leading to improved decision-making, better outcomes, and lower costs. We're tackling neurodegenerative diseases -- starting with multiple sclerosis (MS).
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
William Hagstrom
Chief Operating Officer
Melinda Thomas
Chief Technical Officer
Erwan Rivet
VP - Bus. Development
Maital Shemesh-Rasmussen
Browse more venture capital transactions:
Prev: 10/13/2021: Plume Wireless venture capital transaction
Next: 10/14/2021: The Shift Network venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs